Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett Company

Aurobindo Pharma's US subsidiary recieved U.S. Federal Trade Commission (FTC) approval to proceed with the acquisition of Lannett Company LLC in a deal valued at $250 million, the company announced on Monday.

The acquisition would be carried out on a cash-free, debt-free basis and inclusive of normalized working capital, is expected to close before the end of June 2026. The transaction is expected to be immediately accretive to Aurobindo Group’s earnings per share, it said in a regulatory filing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.